Hydralazine Hydrochloride; Isosorbide Dinitrate Patent Expiration
Hydralazine Hydrochloride; Isosorbide Dinitrate is Used for treating heart failure. It was first introduced by Azurity Pharmaceuticals Inc
Hydralazine Hydrochloride; Isosorbide Dinitrate Patents
Given below is the list of patents protecting Hydralazine Hydrochloride; Isosorbide Dinitrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bidil | US6465463 | Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
Sep 08, 2020
(Expired) | Azurity |
| Bidil | US6784177 | Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
Sep 08, 2020
(Expired) | Azurity |
Hydralazine Hydrochloride; Isosorbide Dinitrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List